ENSG00000137869


Homo sapiens

Features
Gene ID: ENSG00000137869
  
Biological name :CYP19A1
  
Synonyms : CYP19A1 / cytochrome P450 family 19 subfamily A member 1 / P11511
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 15
Strand: -1
Band: q21.2
Gene start: 51208057
Gene end: 51338610
  
Corresponding Affymetrix probe sets: 1554296_at (Human Genome U133 Plus 2.0 Array)   1560295_at (Human Genome U133 Plus 2.0 Array)   203475_at (Human Genome U133 Plus 2.0 Array)   239459_s_at (Human Genome U133 Plus 2.0 Array)   239460_at (Human Genome U133 Plus 2.0 Array)   240705_at (Human Genome U133 Plus 2.0 Array)   240863_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000453149
Ensembl peptide - ENSP00000452872
Ensembl peptide - ENSP00000453280
Ensembl peptide - ENSP00000479587
Ensembl peptide - ENSP00000454039
Ensembl peptide - ENSP00000454004
Ensembl peptide - ENSP00000453318
Ensembl peptide - ENSP00000379683
Ensembl peptide - ENSP00000379685
Ensembl peptide - ENSP00000383930
Ensembl peptide - ENSP00000384389
Ensembl peptide - ENSP00000390614
Ensembl peptide - ENSP00000391139
Ensembl peptide - ENSP00000452627
Ensembl peptide - ENSP00000452667
NCBI entrez gene - 1588     See in Manteia.
OMIM - 107910
RefSeq - NM_001347251
RefSeq - NM_000103
RefSeq - NM_001347248
RefSeq - NM_001347249
RefSeq - NM_001347250
RefSeq - NM_001347252
RefSeq - NM_001347253
RefSeq - NM_001347254
RefSeq - NM_001347255
RefSeq - NM_001347256
RefSeq - NM_031226
RefSeq - XM_005254191
RefSeq Peptide - NP_001334180
RefSeq Peptide - NP_001334181
RefSeq Peptide - NP_001334182
RefSeq Peptide - NP_001334183
RefSeq Peptide - NP_001334184
RefSeq Peptide - NP_001334185
RefSeq Peptide - NP_112503
RefSeq Peptide - NP_000094
RefSeq Peptide - NP_001334177
RefSeq Peptide - NP_001334178
RefSeq Peptide - NP_001334179
swissprot - E9PGZ6
swissprot - E7EQ08
swissprot - A0A024R5S8
swissprot - E7EPL6
swissprot - A0A087WVQ0
swissprot - H0YK57
swissprot - H0YKN1
swissprot - H0YLP1
swissprot - P11511
swissprot - H0YLS2
swissprot - H0YNJ7
Ensembl - ENSG00000137869
  
Related genetic diseases (OMIM): 139300 - Aromatase excess syndrome, 139300
  613546 - Aromatase deficiency, 613546
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 cyp19a1aENSDARG00000041348Danio rerio
 CYP19A1ENSGALG00000013294Gallus gallus
 P28649ENSMUSG00000032274Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
No match


Protein motifs (from Interpro)
Interpro ID Name
 IPR001128  Cytochrome P450
 IPR002401  Cytochrome P450, E-class, group I
 IPR017972  Cytochrome P450, conserved site
 IPR036396  Cytochrome P450 superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0002677 negative regulation of chronic inflammatory response IEA
 biological_processGO:0006694 steroid biosynthetic process TAS
 biological_processGO:0006703 estrogen biosynthetic process TAS
 biological_processGO:0006710 androgen catabolic process IDA
 biological_processGO:0008209 androgen metabolic process IEA
 biological_processGO:0008585 female gonad development IEA
 biological_processGO:0010760 negative regulation of macrophage chemotaxis IEA
 biological_processGO:0016125 sterol metabolic process TAS
 biological_processGO:0022900 electron transport chain IEA
 biological_processGO:0030540 female genitalia development IEA
 biological_processGO:0030879 mammary gland development IEA
 biological_processGO:0055114 oxidation-reduction process IEA
 biological_processGO:0060065 uterus development IEA
 biological_processGO:0060736 prostate gland growth IEA
 biological_processGO:0061370 testosterone biosynthetic process IEA
 biological_processGO:2000866 positive regulation of estradiol secretion IDA
 cellular_componentGO:0005783 endoplasmic reticulum IDA
 cellular_componentGO:0005789 endoplasmic reticulum membrane TAS
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 molecular_functionGO:0004497 monooxygenase activity IEA
 molecular_functionGO:0005506 iron ion binding IEA
 molecular_functionGO:0008395 steroid hydroxylase activity TAS
 molecular_functionGO:0009055 electron transfer activity TAS
 molecular_functionGO:0016491 oxidoreductase activity IEA
 molecular_functionGO:0016705 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen IEA
 molecular_functionGO:0016712 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen TAS
 molecular_functionGO:0019825 oxygen binding TAS
 molecular_functionGO:0020037 heme binding IEA
 molecular_functionGO:0046872 metal ion binding IEA
 molecular_functionGO:0070330 aromatase activity IDA


Pathways (from Reactome)
Pathway description
Estrogen biosynthesis
Endogenous sterols
Defective CYP19A1 causes Aromatase excess syndrome (AEXS)


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000028 Cryptorchidism "Absence of one or both testes from the scrotum owing to failure of the testis or testes to descend through the inguinal canal to the testis." [HPO:curators]
Show

 HP:0000061 Ambiguous genitalia, female 
Show

 HP:0000098 Increased body height 
Show

 HP:0000138 Ovarian cysts 
Show

 HP:0000771 Gynecomastia 
Show

 HP:0000786 Primary amenorrhea 
Show

 HP:0000815 Hypergonadotropic hypogonadism "Reduced function of the gonads (testes in males or ovaries in females) associated with excess pituitary gonadotropin secretion and resulting in delayed sexual development and growth delay." [HPO:curators]
Show

 HP:0000855 Insulin resistance 
Show

 HP:0000938 Osteopenia "Osteopenia refers to a reduction in bone mineral density (BMD) below normal peak BMD but not low enough to be classified as osteoporosis. According to the WHO, osteopenia is characterized by a value of BMD more than 1 standard deviation below the young adult mean, but less than 2 standard deviations below this value." [HPO:curators]
Show

 HP:0000939 Osteoporosis "Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility. According to the WHO, osteoporosis is characterized by a value of BMD 2.5 standard deviations or more below the young adult mean." [HPO:curators]
Show

 HP:0000956 Acanthosis nigricans 
Show

 HP:0001397 Hepatic steatosis 
Show

 HP:0001510 Growth retardation 
Show

 HP:0001513 Obesity "A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY)." [MeSH:D009765]
Show

 HP:0002050 Macroorchidism, postpubertal 
Show

 HP:0002230 Generalized hirsutism "Abnormally increased hair growth over much of the entire body." [HPO:curators]
Show

 HP:0002653 Bone pain 
Show

 HP:0002663 Late ossifying epiphyses 
Show

 HP:0002750 Delayed skeletal maturation "A decreased rate of skeletal maturation. Delayed skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body." [HPO:curators]
Show

 HP:0002857 Genu valgum 
Show

 HP:0003077 Hyperlipidemia 
Show

 HP:0003251 Male infertility 
Show

 HP:0003782 Eunuchoid habitus 
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0005616 Accelerated skeletal maturation "An abnormally increased rate of skeletal maturation. Accelerated skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body." [HPO:curators]
Show

 HP:0005978 Noninsulin-dependent diabetes mellitus 
Show

 HP:0008072 Maternal virilization 
Show

 HP:0008222 Female infertility 
Show

 HP:0008675 Enlarged polycystic ovaries 
Show

 HP:0010458 Female pseudohermaphroditism "Hermaphroditism refers to a discrepancy between the morphology of the gonads and that of the external genitalia. In female pseudohermaphroditism, the genotype is female (XX) and the gonads are ovaries, but the external genitalia are virilized." [HPO:curators]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr